A Tight Junction-Associated Merlin-Angiomotin Complex Mediates Merlin's Regulation of Mitogenic Signaling and Tumor Suppressive Functions-Reference-Cited by-同舟云学术

A Tight Junction-Associated Merlin-Angiomotin Complex Mediates Merlin's Regulation of Mitogenic Signaling and Tumor Suppressive Functions

Published:2011-04 Issue:4 Volume:19 Page:527-540
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Yi Chunling,Troutman Scott,Fera Daniela,Stemmer-Rachamimov Anat,Avila Jacqueline L.,Christian Neepa,Persson Nathalie Luna,Shimono Akihiko,Speicher David W.,Marmorstein Ronen,Holmgren Lars,Kissil Joseph L.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference44 articles.

1. Cyclic AMP-dependent protein kinase phosphorylates merlin at serine 518 independently of p21-activated kinase and promotes merlin-ezrin heterodimerization;Alfthan;J. Biol. Chem.,2004

2. Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma;Ammoun;Cancer Res.,2008

3. Role of group A p21-activated kinases in activation of extracellular-regulated kinase by growth factors;Beeser;J. Biol. Chem.,2005

4. Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver;Benhamouche;Genes Dev.,2010

5. Contact-dependent inhibition of EGFR signaling by Nf2/Merlin;Curto;J. Cell Biol.,2007

Cited by 221 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNA-135b mainly functions as an oncogene during tumor progression;Pathology - Research and Practice;2024-10

2. NF2-Related Schwannomatosis (NF2): Molecular Insights and Therapeutic Avenues;International Journal of Molecular Sciences;2024-06-14

3. Angiomotin family proteins in the Hippo signaling pathway;BioEssays;2024-05-17

4. RICH1 is a novel key suppressor of isoproterenol‑ or angiotensin II‑induced cardiomyocyte hypertrophy;Molecular Medicine Reports;2024-03-04

5. NF2 is a candidate diagnosis, prognostic, and immunotherapeutic biomarker: a systematic pan-cancer analysis;Translational Cancer Research;2024-02